CD274 and neoplasm: These tumor-infiltrating lymphocytes (TILs) were suggested to be related to the response of immune checkpoints such as PD-1 and PD-L1 [25, 52], so that the efficacy of PD-1/PD-L1 inhibitors may be differed between high- and low-risk patients.